Screener
Allogene Therapeutics ALLO Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Allogene Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
FAQ
- What is Allogene Therapeutics's net margin?
- Allogene Therapeutics (ALLO) reported net margin of -1,170,863.6% in Q4 2024.
- How has Allogene Therapeutics's net margin changed year-over-year?
- Allogene Therapeutics's net margin decreased by 239.9% year-over-year, from -344,489.5% to -1,170,863.6%.
- What is the long-term trend for Allogene Therapeutics's net margin?
- Over 3 years (2021 to 2024), Allogene Therapeutics's net margin has grown at a 1842.9% compound annual growth rate (CAGR), from -159.6% to -1,170,863.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Allogene Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude